H1N1 vaccine considered 'safe' by U.S. health officials and WHO states Tamiflu is still effective

Following the latest news this week that the World Health Organization (WHO) had received reports from both the U.K. and the the U.S. on H1N1 swine flu mutations and resistance to drugs, WHO has stated that Tamiflu should still be used in the majority of cases for H1N1 swine flu treatment. In addition, although the recent H1N1 vaccine recall in Canada may make people reconsider having the H1N1 vaccine, U.S. officials have stated that the H1N1 vaccine is still 'safe'.
Using Tamiflu to treat H1N1 swine flu
Tamiflu proved ineffective in treating H1N1 swine flu in cases in both the U.S. and the U.K. but these incidences were with people who all had a “compromised immune system”. WHO officials have now stated that Tamiflu was still an effective drug in treating H1N1 swine flu in “the majority of cases”.
The safety of the H1N1 vaccine
News on the recall of a batch of H1N1 vaccines in Canada earlier in the week may have prompted fears over the safety of the H1N1 vaccine in the U.S. However, U.S. health officials have reported that the H1N1 vaccine is 'safe', and where side effects have been reported, the majority have been 'minor'. Many pregnant women however are still concerned over reported miscarriages and the effect of the ingredient thirmerosal in H1N1 vaccines.